Bacterial Vaginosis That Keeps Coming Back: What a 2026 Analysis Found About Prevention

Bacterial vaginosis, usually shortened to BV, has an unfair reputation. Many people think of it as a hygiene problem or something embarrassing to bring up, yet it affects about one third of reproductive-aged women [2]. The frustrating part usually comes after treatment, when symptoms return a few weeks or months later. Researchers behind a new analysis published in October set out to compare which prevention strategies lower the chance of that happening.

What the network meta-analysis found
BV happens when the usual balance of vaginal bacteria changes. Normally Lactobacillus species are dominant. In BV, other bacteria overgrow, mostly ones that grow without oxygen [4]. Standard antibiotics clear the infection in the short term, yet recurrence is common [3, 4].
Researchers at the University of Pavia in Italy pooled randomized trials in non-pregnant women to compare three types of prevention [1]. Their study is a network meta-analysis. That design lets researchers compare treatments that were never tested head to head, using the trials they share in common. They reported three main results [1]:
Partner treatment. Treating a male sexual partner lowered the recurrence rate by about 24% compared with no partner treatment.
Short-term follow-up right after antibiotics. Vaginal acidifying products, vaginal probiotics, and oral probiotics each reduced early recurrence or persistence compared with placebo. The researchers rated the certainty of evidence as moderate for the first two and low for oral probiotics.
Long-term prevention. Vaginal probiotics were the only option with a statistically significant benefit across everyone in the long-term analysis, lowering recurrence by about 26%.
The researchers also split women by their baseline risk of BV returning. For women at low baseline risk, oral probiotics and acidifying products performed best. For women at high baseline risk, vaginal probiotics and ongoing intermittent antibiotic suppression showed the largest reductions [1]. Their conclusion was that vaginal Lactobacillus products and acidifying agents have the most support among the non-antibiotic options [1].
Should partners be treated too?
This is where the research is still unsettled. In the open-label 2025 NEJM trial, couples in a monogamous relationship were randomized so that either only the woman was treated or both partners were treated, with the male partner using both an oral antibiotic and an antibiotic cream applied to the skin of the penis [2]. The trial was stopped early because treating only the woman was clearly less effective. Within 12 weeks, BV came back in 35% of women whose partners were treated, compared with 63% of women whose partners were not [2]. Side effects in the men were mild and included nausea, headache, and a metallic taste.
Two other meta-analyses published this year came to a more cautious conclusion. One pooled eight randomized trials and found no overall effect of partner treatment on recurrence or cure [4]. The authors noted a benefit among couples who followed the treatment fully, particularly in the newer trial that used combined oral and topical therapy [4]. Another pooled six trials with 953 couples and also found no overall effect, while pointing out that the 2025 trial was the only one to treat partners with both a pill and a cream [5]. When that trial was removed from the analysis, the remaining studies had a neutral result [5].
What this means is that older trials that treated partners with a single medication did not show a benefit, and one newer, more intensive approach did. That is promising, and it still comes from one trial.
Why the vaginal microbiome needs rebuilding as well as clearing
As a naturopathic doctor, I find the probiotic results the most encouraging part of this research. Antibiotics remove the overgrowth, but they do not put the protective bacteria back. Researchers have described BV recurrence as partly a failure of Lactobacillus to repopulate the vagina after antibiotics, and Lactobacillus crispatus in particular is strongly associated with vaginal health [3].
A probiotic might only help once the antibiotics have fully cleared the BV. In a follow-up analysis of a randomized trial testing a vaginal L. crispatus product, the probiotic lowered recurrence at 12 weeks only in women whose BV had cleared after their initial antibiotic course [6]. In women whose BV had not fully cleared, it did not help, and those women also had lower levels of the probiotic strain detectable afterward [6]. One possible explanation is that protective bacteria have a harder time colonizing the vagina while BV is still present.
Recurrent BV can affect your sex life and your confidence, and it deserves to be taken seriously rather than brushed off.
What to ask your provider when BV returns
If BV keeps returning for you, these are questions to raise with your provider:
Was my BV fully cleared after treatment? It may help to ask about a recheck, since the trial data suggest probiotics work best once the infection has cleared [6].
Would a vaginal probiotic or an acidifying product make sense for me? These had the most support among non-antibiotic options in the 2026 analysis [1].
Should my partner be treated? The research is mixed, and a combined approach for male partners showed a benefit in one trial [2]. That is a decision you, your partner, and your clinician can make together.
Is ongoing suppression an option? For people with frequent recurrences, the analysis found intermittent antibiotic suppression was among the most effective options in the high-risk group [1].
Most of these trials enrolled women in relationships with men, so there is less research on people in other relationships. If that describes you, I'd mention it at your appointment so the plan can account for it.
References
Gardella B, Dominoni M, Pano MR, Lovotti A, Spinillo A. Rethinking Prevention of Recurrent Bacterial Vaginosis: A Comparative Effectiveness Network Meta-Analysis. J Low Genit Tract Dis. 2026;30(4):325-340. PMID 42611724. doi:10.1097/LGT.0000000000000966. https://pubmed.ncbi.nlm.nih.gov/42611724/
Vodstrcil LA, Plummer EL, Fairley CK, et al. Male-Partner Treatment to Prevent Recurrence of Bacterial Vaginosis. N Engl J Med. 2025;392(10):947-957. PMID 40043236. doi:10.1056/NEJMoa2405404
Lagenaur LA, Hemmerling A, Chiu C, et al. Connecting the Dots: Translating the Vaginal Microbiome Into a Drug. J Infect Dis. 2021;223(12 Suppl 2):S296-S306. PMID 33330916. doi:10.1093/infdis/jiaa676
Aliyu Attahir Z, Chaithongwongwatthana S, Ibrahim A, Lawal B. Male Partner Treatment for Bacterial Vaginosis: A Systematic Review and Meta-Analysis of Randomized Trials. Sex Transm Dis. 2026;53(11):846-852. PMID 42861563. doi:10.1097/OLQ.0000000000002368
Pacheco Vieira LL, Suruagy-Motta RFO, Bomfim JQ, et al. The efficacy of male partner treatment to prevent recurrence of bacterial vaginosis: A systematic review with meta-analysis of randomized controlled trials. Eur J Obstet Gynecol Reprod Biol. 2026;321:115047. PMID 41780137. doi:10.1016/j.ejogrb.2026.115047
Hemmerling A, Wierzbicki MR, Armstrong E, Cohen CR. Response to Antibiotic Treatment of Bacterial Vaginosis Predicts the Effectiveness of LACTIN-V (Lactobacillus crispatus CTV-05) in the Prevention of Recurrent Disease. Sex Transm Dis. 2024;51(6):437-440. PMID 38733973. doi:10.1097/OLQ.0000000000001962
This post is for education only and is not medical advice. Vaginal symptoms can have several causes, including yeast and sexually transmitted infections, so please see a provider for testing rather than self-treating. If you are pregnant, talk with your provider before starting any probiotic or other product.
If this resonates with what you're experiencing and you'd like to explore a naturopathic approach, book a consultation with our clinic.




Comments